Depression and anxiety have unique contributions to somatic complaints in depression, irritable bowel syndrome and inflammatory bowel diseases


Creative Commons License

YANARTAŞ Ö., Kani H. T., Kani A., Akca Z. N. D., Akca E., Ergun S., ...Daha Fazla

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.29, sa.4, ss.418-426, 2019 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1080/24750573.2019.1589177
  • Dergi Adı: PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.418-426
  • Anahtar Kelimeler: Depression, anxiety, somatic symptoms, brain gut axis, inflammatory bowel diseases, irritable bowel syndrome, FUNCTIONAL GASTROINTESTINAL DISORDERS, TORONTO-ALEXITHYMIA-SCALE, PRIMARY-CARE, SYMPTOMS, INVENTORY, SOMATIZATION, AMPLIFICATION, RELIABILITY, PREVALENCE, MANAGEMENT
  • Marmara Üniversitesi Adresli: Evet

Özet

OBJECTIVE: In this study we aim to investigate the effects of somatic and related symptoms (SARS), alexithymia, hypochondriasis, anxiety and depression on patients with major depressive disorder, irritable bowel syndrome, inflammatory bowel disease which are the representative diseases of brain gut axis (BGA).